{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:37:42Z","timestamp":1768480662784,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.hpb.2019.10.2447","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T18:45:14Z","timestamp":1574793914000},"page":"1168-1173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic factors and patterns of loco-regional failure in patients with R0 resected gallbladder cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Jung Ho","family":"Im","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Kyoung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsil","family":"Seong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2019.10.2447_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MCG.0b013e3182703409","article-title":"Prognostic factors in patients with gallbladder cancer after surgical resection: analysis of 279 operated patients","volume":"47","author":"Lim","year":"2013","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.hpb.2019.10.2447_bib2","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1007\/s11605-015-2922-0","article-title":"Adjuvant therapy for gallbladder cancer: an analysis of the national cancer data base","volume":"19","author":"Hoehn","year":"2015","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2019.10.2447_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw324","article-title":"Limited use of adjuvant therapy in patients with resected gallbladder cancer despite a strong association with survival","volume":"109","author":"Mitin","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hpb.2019.10.2447_bib4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.hpb.2016.05.016","article-title":"Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium","volume":"18","author":"Margonis","year":"2016","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2019.10.2447_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3857\/roj.2017.00388","article-title":"Patterns of initial failure after resection for gallbladder cancer: implications for adjuvant radiotherapy","volume":"35","author":"Kim","year":"2017","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.hpb.2019.10.2447_bib6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.18.00050","article-title":"Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study","volume":"37","author":"Edeline","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2019.10.2447_bib7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hpb.2019.10.2447_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jso.21544","article-title":"Adjuvant chemoradiation therapy in gallbladder cancer","volume":"102","author":"Cho","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2019.10.2447_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijrobp.2017.09.029","article-title":"Concurrent chemoradiotherapy in curatively resected gallbladder carcinoma: a propensity score-matched analysis","volume":"100","author":"Gu","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hpb.2019.10.2447_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/cncr.30968","article-title":"The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts","volume":"124","author":"Tran Cao","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2019.10.2447_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1245\/s10434-017-6139-1","article-title":"Adjuvant chemoradiotherapy is associated with improved survival for patients with resected gallbladder carcinoma: a systematic Review and meta-analysis","volume":"25","author":"Kim","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2019.10.2447_bib12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijrobp.2008.10.052","article-title":"Adjuvant therapy for gallbladder carcinoma: the mayo clinic experience","volume":"75","author":"Gold","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hpb.2019.10.2447_bib13","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3346\/jkms.2014.29.10.1333","article-title":"Practical guidelines for the surgical treatment of gallbladder cancer","volume":"29","author":"Lee","year":"2014","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.hpb.2019.10.2447_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000486207","article-title":"Laparoscopic surgery for gallbladder cancer: an expert consensus statement","volume":"36","author":"Han","year":"2019","journal-title":"Dig Surg"},{"key":"10.1016\/j.hpb.2019.10.2447_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000486208","article-title":"Survey results of the expert meeting on laparoscopic surgery for gallbladder cancer and a Review of relevant literature","volume":"36","author":"Yoon","year":"2019","journal-title":"Dig Surg"},{"key":"10.1016\/j.hpb.2019.10.2447_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000339695","article-title":"Patterns of initial disease recurrence after resection of biliary tract cancer","volume":"83","author":"Jung","year":"2012","journal-title":"Oncology"},{"key":"10.1016\/j.hpb.2019.10.2447_bib17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11605-009-1140-z","article-title":"Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma","volume":"14","author":"Kim","year":"2010","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2019.10.2447_bib18","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/cncr.11699","article-title":"Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies","volume":"98","author":"Jarnagin","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2019.10.2447_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5009\/gnl18105","article-title":"Incidence and overall survival of biliary tract cancers in South Korea from 2006 to 2015: using the national health information database","volume":"13","author":"Kim","year":"2019","journal-title":"Gut Liver"},{"key":"10.1016\/j.hpb.2019.10.2447_bib20","first-page":"99","article-title":"Gallbladder cancer: epidemiology and outcome","volume":"6","author":"Hundal","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.hpb.2019.10.2447_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijsu.2018.02.052","article-title":"Adjuvant systemic therapy after resection of node positive gallbladder cancer: time for a well-designed trial? (Results of a US-national retrospective cohort study)","volume":"52","author":"Bergquist","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.hpb.2019.10.2447_bib22","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4143\/crt.2015.502","article-title":"Is there a role for adjuvant therapy in R0 resected gallbladder cancer?: a propensity score-matched analysis","volume":"48","author":"Go","year":"2016","journal-title":"Cancer Res Treat"},{"issue":"Suppl 3","key":"10.1016\/j.hpb.2019.10.2447_bib23","doi-asserted-by":"crossref","first-page":"S1100","DOI":"10.1245\/s10434-015-4685-y","article-title":"Evaluation of adjuvant radiation therapy for resected gallbladder carcinoma: a multi-institutional experience","volume":"22","author":"Wang","year":"2015","journal-title":"Ann Surg Oncol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X19331910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X19331910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:28:37Z","timestamp":1761265717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X19331910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1365182X19331910"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2019.10.2447","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors and patterns of loco-regional failure in patients with R0 resected gallbladder cancer","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2019.10.2447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd on behalf of International Hepato-Pancreato-Biliary Association Inc.","name":"copyright","label":"Copyright"}]}}